Genomic Valley Biotech reported no net profit/loss in the quarter ended September 2025 as against net profit of Rs 0.15 crore during the previous quarter ended September 2024. Sales declined 57.14% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 0.09 | 0.21 | -57 |
| OPM % | 0 | 66.67 | - |
| PBDT | 0 | 0.15 | -100 |
| PBT | 0 | 0.15 | -100 |
| NP | 0 | 0.15 | -100 |